SCHEMBL6133040

SCHEMBL6133040

CC(C)NC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccc(=O)n(C(C)C)n2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 2/20 0.40
ALOX15 P16050 2/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
PTGS2 P35354 1/20 0.38
HSD17B10 Q99714 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
RET P07949 1/20 0.35
ALDH1A1 P00352 3/20 0.35
PKM P14618 1/20 0.35
KDM4E B2RXH2 2/20 0.35
CSNK1D P48730 1/20 0.35
CSNK1E P49674 1/20 0.35
TGFBR1 P36897 2/20 0.35
TGFBR2 P37173 2/20 0.35
SCN9A Q15858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134790 0.91 TGFBR1 (0.41) GABRA5ALOX15TSHRHDAC6PTGS2
SCHEMBL6133813 0.90 ALOX15 (0.46) ALOX15TSHRCASP1PTGS2ADORA2A
SCHEMBL6134138 0.88 RORC (0.40) GABRA5ALOX15TSHRCASP1HSD17B10
SCHEMBL6133744 0.88 HDAC6 (0.38) GABRA5HDAC6PTGS2HSD17B10NPC1
SCHEMBL6133930 0.88 RET (0.42) HDAC6PTGS2ADORA2AADORA1RET
SCHEMBL6133269 0.86 HPGD (0.42) GABRA5HDAC6NPC1RAB9AALDH1A1
SCHEMBL6133569 0.86 HDAC6 (0.45) HDAC6PTGS2HSD17B10NPC1RAB9A
SCHEMBL6134156 0.85 TSHR (0.42) GABRA5ALOX15TSHRCASP1HSD17B10
SCHEMBL6133158 0.85 PTGS2 (0.56) ALOX15PTGS2HSD17B10NPC1RAB9A
SCHEMBL6923908 0.84 HDAC6 (0.35) HDAC6PTGS2ADORA2AADORA1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR GABRA5 1278/4885ALOX15 1491/4885TSHR 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.